Option Care Health delivered a strong finish to 2025, with Q4 revenue growing 8.8% year-over-year to $1.47 billion. While net income saw a slight decline of 2.7%, the company achieved growth in Adjusted EBITDA and Adjusted Diluted EPS, while returning $95 million to shareholders through stock repurchases in the quarter.

Option Care Health delivered a strong third quarter with net revenue increasing by 12.2% year-over-year to $1.435 billion. While net income saw a slight decrease of 3.8%, adjusted diluted EPS grew by 9.8% to $0.45, and adjusted EBITDA increased by 3.4% to $119.5 million, demonstrating balanced growth and operational strength.

Option Care Health reported a strong second quarter in 2025, with net revenue increasing by 15.4% to $1,416.1 million and adjusted diluted earnings per share rising by 10.8% to $0.41. While net income saw a slight decrease, the company demonstrated resilience and continued to focus on providing strong clinical outcomes.

Option Care Health reported strong first quarter 2025 financial results, demonstrating significant year-over-year growth in net revenue, gross profit, net income, adjusted net income, and adjusted EBITDA, driven by solid execution.

Option Care Health delivered solid financial results in Q4 2024 with net revenue growth of 19.7%, increased net income, and a higher adjusted EBITDA, demonstrating resilience in a dynamic market environment.

Option Care Health reported a 17.0% increase in net revenue to $1,278.5 million for the third quarter of 2024. Net income was $53.9 million, or $0.31 per diluted share, while adjusted EBITDA reached $115.6 million. The company faces supply chain disruptions expected to negatively impact fourth-quarter results.

Option Care Health reported net revenue of $1,227.2 million, a 14.8% increase compared to the second quarter of 2023. Net income was $53.0 million, or $0.30 diluted earnings per share. Adjusted EBITDA was $108.4 million, and cash flow from operations was $195.7 million.

Option Care Health reported a 12.8% increase in net revenue to $1,146.1 million for Q1 2024, with net income rising by 14.2% to $44.8 million. Adjusted EBITDA increased by 4.8% to $98.3 million. The company reaffirmed its commitment to patient care while navigating a challenging environment.

Option Care Health reported Q4 2023 financial results, with a revenue of $1,124.4 million, a 9.5% increase compared to Q4 2022. Net income was $57.2 million, or $0.32 earnings per share. Adjusted EBITDA reached $111.6 million, an 18.4% increase compared to the prior year. The company also fulfilled $250 million in share repurchases and authorized an additional $250 million.

Option Care Health reported net revenue of $1,093.0 million, a 7.1% increase compared to the third quarter of 2022. Net income increased by 45.0% to $56.3 million, or $0.31 basic earnings per share. Adjusted EBITDA was $109.8 million, up 28.2% from the previous year.

Option Care Health reported a strong second quarter in 2023, with a 9.0% increase in net revenue to $1,069.1 million and a significant 237.2% rise in net income to $114.4 million. The company's adjusted EBITDA also saw a substantial increase of 29.2%, reaching $110.1 million. Despite terminating the Merger Agreement with Amedisys, Inc. and receiving a termination fee, the company remains confident in its growth trajectory for the remainder of the year.

Option Care Health reported a strong first quarter in 2023, with a 10.9% increase in net revenue, a 29.5% increase in net income, and a 20.6% increase in Adjusted EBITDA. The company also completed a $75.0 million stock repurchase and launched Naven Health.

Option Care Health reported net revenue of $1,027.2 million for Q4 2022, up 10.8% compared to the same period in 2021. Net income for the quarter was $47.5 million, or $0.26 earnings per share. Adjusted EBITDA was $94.3 million, an increase of 8.7% compared to Q4 2021.

Option Care Health reported a strong third quarter with a 14.5% increase in net revenue, a 7.4% increase in gross profit, and a 9.8% increase in adjusted EBITDA. The company's focus on patient care and strategic investments drove solid financial results despite inflationary pressures.

Option Care Health reported strong financial results for Q2 2022, with a 14.0% increase in net revenue compared to Q2 2021. The company's net income and Adjusted EBITDA also increased, and cash flow from operations improved.

Option Care Health reported a strong first quarter in 2022, with a 20.6% increase in net revenue, a significant rise in gross profit, and a shift from net loss to net income. The company's adjusted EBITDA also saw a substantial increase, and cash flow from operations improved significantly.

Option Care Health reported a strong fourth quarter and full year in 2021, marked by a 15.2% increase in net revenue for Q4, reaching $927.2 million, and a net income of $75.5 million. The company's adjusted EBITDA for Q4 grew by 28.3% to $86.8 million. Additionally, Option Care Health completed the acquisition of Wasatch Infusion LLC and announced a definitive agreement to acquire Specialty Pharmacy Nursing Network, Inc.

Option Care Health announced financial results for the third quarter ended September 30, 2021, with net revenue of $891.9 million, a 14.1% increase compared to the third quarter of 2020. The company reported a net income of $35.5 million, or $0.20 per share, and an adjusted EBITDA of $78.0 million, up 31.7% compared to the third quarter of 2020.

Option Care Health reported a strong second quarter with a 16.1% increase in net revenue, reaching $860.3 million. The company also saw significant improvements in gross profit, net income, and adjusted EBITDA. Based on this momentum, the company raised its full-year financial guidance.

Option Care Health reported a 7.6% increase in net revenue to $759.2 million and a 30.0% increase in Adjusted EBITDA to $52.2 million compared to the first quarter of 2020. The company experienced a net loss of $2.9 million, or $0.02 loss per share, improved from a net loss of $19.9 million, or $0.11 loss per share, in the same period last year.

Option Care Health reported a strong fourth quarter with a revenue increase of 11.6% and net income of $17.8 million, a significant turnaround from the net loss in the same quarter of the previous year. The company also provided financial guidance for the full year 2021.

Option Care Health announced financial results for the third quarter ended September 30, 2020. Net revenue was $781.6 million, up 27% compared to the third quarter of 2019. Net income was $1.7 million, or $0.01 per share, compared to net loss of $42.8 million, or $0.26 loss per share, in the third quarter of 2019. Adjusted EBITDA was $59.2 million, up 70% compared to the third quarter of 2019.

Option Care Health announced strong second-quarter results, with a 49% increase in net revenue and a 131% increase in Adjusted EBITDA compared to the second quarter of 2019. The company's performance was impacted by the COVID-19 pandemic, but it managed to offset negative factors by transferring existing patients to home or infusion suites.

Option Care Health announced strong financial results for the first quarter ended March 31, 2020, with a net revenue of $705.4 million, up 48.0% compared to the first quarter of 2019. The company reported a net loss of $19.9 million, or $0.11 per share, and an adjusted EBITDA of $40.2 million, up 107.6% compared to the first quarter of 2019. The company's cash flow from operations was $18.4 million, and it had cash balances of $77.2 million at the end of the quarter.

Option Care Health announced financial results for Q4 and full year 2019. Net revenue for Q4 was $720.8 million, up 42.5% compared to Q4 2018. Net loss was $15.8 million, compared to net income of $3.3 million in Q4 2018. Adjusted EBITDA was $53.0 million, up 70.0% compared to Q4 2018.